Quarterly report pursuant to Section 13 or 15(d)

Industry Segments (Tables)

v3.20.4
Industry Segments (Tables)
3 Months Ended
Dec. 31, 2020
Industry Segments [Abstract]  
Schedule of Segment Reporting Information



 

 

 

 

 

   

Three Months Ended



December 31,



2020

 

2019



 

 

 

 

 

Sexual health business

$

9,910,779 

 

$

5,969,063 

Research and development

 

(5,858,837)

 

 

(5,289,859)

Corporate

 

15,135,215 

 

 

(2,463,597)

Operating income (loss)

$

19,187,157 

 

$

(1,784,393)